Weight-Loss Drugs Spark Shift in Cosmetic Surgery Demand, Favoring Natural Aesthetics and Skin Tightening

The burgeoning popularity of weight-loss drugs like Mounjaro and Foundayo is significantly altering the landscape of the beauty industry, leading to a noticeable decline in demand for traditional cosmetic procedures. An international survey by the International Society of Aesthetic Plastic Surgery (ISAPS), which gathered data from over 2,900 surgeons across 51 countries, revealed a decrease in cosmetic surgeries performed in 2025. The study indicated that cosmetic procedures for men dropped by 14% and for women by 7.7% in 2025 compared to the previous year, continuing a downward trend that saw a 4% decrease for women in 2024.

Specific procedures have seen substantial declines. Demand for liposuction fell by 11.4% in 2025, following a 12.6% reduction in 2024. Similarly, breast augmentation and Botox have experienced a slide, with demand decreasing by 17% in 2024 and an additional 2% and 7% respectively last year. Dr. Sanjay Parashar, CEO of Cocoona Centre of Aesthetic Transformation in Dubai, attributes these shifts to the widespread adoption of weight-loss drugs, while economic pressures may be influencing men's decisions regarding cosmetic procedures.

Dr. Parashar noted that while liposuction procedures have decreased due to oral weight-loss medications effectively targeting stubborn fat, there has been a corresponding rise in demand for procedures like facelifts and bodylifts. He suggests that patients are now preferring tightening procedures for a more natural and cost-effective outcome over non-surgical options like fillers, which can lead to unnatural appearances. He also anticipates that the advent of newer